cancer sequencing
Ultima Genomics, Exact Sciences Ink Long-Term Sequencing Supply Agreement
In conjunction with the deal, Exact Sciences also made an investment of undisclosed size into Ultima Genomics and joined the firm’s early-access program.
Thermo Fisher Scientific Obtains CE Mark for Ion Torrent Genexus Dx Integrated Sequencer
The company is developing a sample-to-report diagnostic workflow and a portfolio of clinically validated assays for the sequencing platform.
Mass General, Lunaphore Technologies to Develop Test to Predict PARP Inhibitor Response
The collaboration between Mass General and Switzerland's Lunaphore will initially focus on developing a test for ovarian, breast, and prostate cancers.
BostonGene Partners with NEC to Offer Tumor Portrait Tests Internationally
NEC, an investor in BostonGene, will initially help provide Tumor Portrait to hospitals in Japan using its healthcare and life science network.
The US Federal Trade Commission's recent challenge raises the question who Illumina can acquire while remaining a quasi-monopolist for sequencing equipment.
Feb 25, 2021
Natera Revenues Grow 35 Percent in Q4
Feb 25, 2021
NantHealth Q4 Revenues Flat From Year Ago
Nov 5, 2020
NantHealth Q3 Revenues Tick Up Slightly
Sep 11, 2020
Natera Prices $250M Public Stock Offering
Aug 6, 2020
NantHealth Q2 Revenues Decline 12 Percent
Jul 29, 2020